Complementary and alternative medicine for treating amyotrophic lateral sclerosis: a narrative review

BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative disease that is characterized by selective motor neuron cell death in the motor cortex, brainstem, and spinal cord. Two drugs for ALS, riluzole and edaravone, have been approved by FDA for the treatment of ALS patients. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Mudan, Yang, Eun Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806396/
https://www.ncbi.nlm.nih.gov/pubmed/31692669
http://dx.doi.org/10.1016/j.imr.2019.08.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806396/
https://www.ncbi.nlm.nih.gov/pubmed/31692669
http://dx.doi.org/10.1016/j.imr.2019.08.003

Ejemplares similares